| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.088 | 0.07 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.084 | 0.09 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.087 | 0.09 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.047 | 0.3 |